Bath & Body Works (BBWI) shares plummeted 25% on November 20 to $15.82—their largest single-day drop in over five years—after the retailer missed earnings and cut its full-year forecast. In the days that followed, six company directors made significant share purchases, signaling insider confidence despite a grim year in which the stock has fallen 51% (vs. the S&P 500's 17% gain).

Director Purchases (November 21-24):

• Lucy Brady (President, Conagra Brands): Bought 3,470 shares at $14.40. Holdings: ~17,482 shares ($329,186 value).
• Stephen Steinour (CEO, Huntington Bancshares): Bought 6,700 shares at $14.86. Total direct/indirect holdings: ~80,900 shares (~$1.5M value).
• Francis Hondal (Former Mastercard exec): Bought 3,343 shares at ~$15.00. Holdings: 21,554 shares ($405,861 value).
• Steven Voskuil (CFO, Hershey): Bought 20,000 shares at $15.04—the largest purchase. Holdings: 33,925 shares ($638,807 value).
• Sarah Nash (Board Chair): Bought 10,000 shares at $15.58. Holdings: 285,522 shares (~$5.4M value).
• James Symancyk (CEO, Signet Jewelers): Bought 22,500 shares at $15.58. Holdings doubled to 40,379 shares ($760,336 value).

Company Context:
New CEO Daniel Heaf attributed the weak results to "strategic missteps" under prior leadership—including a push into hair care, laundry detergent, and men's grooming—and consumer economic concerns. Heaf cautioned that a turnaround "will take time" to reflect in financial performance.

Why It Matters:
Insider purchases often signal leadership's belief that the stock is undervalued and that recovery plans are credible. The concentrated buying following a severe sell-off suggests directors see a path forward, though Heaf's timeline indicates patience is required. The stock closed Friday at $18.83, still down significantly for the year.